BioSpace News Archive

BCV announces a major step in the development and evaluation of steerable mechatronic guidewires for stroke treatment – the GECKO System.

Myndlift, a health technology company that offers digital mental health programs using the Muse® leading consumer EEG technology platform, recently completed a retrospective study using real-world data that offers preliminary efficacy of remote neurofeedback therapy (NFT) on improved mental health outcomes from 593 participants.

BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company specializing in targeted immunotherapies for cancer, announces a poster presentation at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting, held November 10-12, 2022, in Boston, MA.

CytoAgents, Inc., a clinical-stage therapeutics company developing a safe, effective treatment (CTO1681) for Cytokine Release Syndrome (CRS), today announced that it has strengthened its leadership team with the appointment of Arthur P. Bertolino MD, PhD, MBA, as Chief Medical Officer.

Apollo NeuroscienceTM, makers of the first scientifically-validated wearable that improves the body’s resilience to stress, is running an IRB-approved clinical trial with the support of the Multidisciplinary Association for Psychedelic Studies (MAPS), a nonprofit sponsoring the most advanced clinical trials of a psychedelic-assisted therapy.

SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), today announced that it has entered into an expanded global, non-exclusive license and collaboration agreement with GSK plc (LSE/NYSE: GSK) for nirogacestat, SpringWorks’ investigational oral gamma secretase inhibitor, in combination with Blenrep (belantamab mafodotin-blmf), GSK’s antibody-drug conjugate targeting B-cell maturation antigen (BCMA).

Monteris Medical announced today that the first patient has been enrolled in its REMASTer (Recurrent Brain Metastases After Stereotactic Radiosurgery [SRS] Trial) clinical trial.

Agadia Systems, Inc. (Agadia), a recognized healthcare technology solution provider for over 50 of the nation’s leading Health Plans & PBMs, is announcing an integration with language solutions provider, CQ fluency, to provide translation services within Agadia’s prior authorization solution, PAHub.

The healthcare industry is readily aspiring new technology that can enable caregivers to treat their patients better and the advent of intraoperative imaging has been in sync with it.

Hospital-acquired infections are a highly prevalent adverse events in the health care industry. Presence of unhygienic conditions in and around hospitals along with improper sterilization techniques applied in these settings augments the prevalence of hospital-acquired infections in the low and middle income countries.